Psychiatric medicines can help older adults, but age-related health changes, multiple prescriptions, and increased sensitivity to some effects require careful review. The aim is useful treatment with manageable risk, not withholding care because of age. Decisions should reflect the person's goals, functioning, physical health, and preferences.
Assess symptoms and possible contributing conditions
Depression, anxiety, psychosis, and insomnia deserve assessment in later life. New confusion or behavior change may also reflect delirium, illness, pain, medication effects, or sensory problems. A rapid change should not automatically be treated as a new psychiatric diagnosis.
Review timing, physical symptoms, sleep, cognition, bereavement, and social circumstances. Hearing or vision difficulties can affect communication and interpretation of symptoms. The person's own account remains important, with caregiver information included appropriately when helpful.
Changes in medicine handling affect safety
Kidney and liver function, body composition, frailty, and interacting treatments can alter exposure or sensitivity. A medicine tolerated years ago may become less suitable after illness or a new prescription. Dose decisions should be individualized and accompanied by review of actual benefit.
Sedation, dizziness, blood-pressure changes, falls, and cognitive effects can have substantial consequences. Some antidepressants can contribute to low sodium in susceptible people, and some drugs have anticholinergic effects. Monitoring should focus on risks relevant to the exact regimen.
Areas to review in later life
| Concern | Why it matters |
|---|---|
| Falls and balance | Sedation, dizziness and interacting medicines can accumulate |
| Cognition | Drug effects and delirium may resemble worsening memory problems |
| Kidney function | Important for medicines such as lithium and several other treatments |
| Anticholinergic burden | Can affect constipation, urination, vision and cognition |
| Multiple prescriptions | Raises interaction and duplication concerns |
| Practical use | Packaging, memory, swallowing, cost and supply |
Antipsychotics in dementia require particular caution
Antipsychotics have an increased-mortality warning for older people with dementia-related psychosis. This needs an explicit benefit-risk discussion. Distress or behavior change should first prompt assessment of pain, delirium, environment, communication, and other contributors.
Selected medicines may have specific approvals for particular dementia-related symptoms, but this does not remove the need for careful selection, monitoring, and review. A drug should not be continued indefinitely without assessing benefit and whether the original indication remains.
Review the whole regimen and consider supported reduction
A medication review should identify the purpose of each drug, duplicate effects, interactions, and whether the person still benefits. Deprescribing can be appropriate when a medicine no longer helps or its risks outweigh benefit, but it is a clinical process rather than simply removing prescriptions.
Benzodiazepines, antidepressants, and other treatments may need gradual changes to avoid withdrawal or recurrence. Altering several medicines at once can make effects difficult to interpret. The plan should state what changes first, what will be monitored, and who will provide follow-up.
Make treatment accessible and preserve choice
Ask about swallowing, packaging, reminders, pharmacy support, and the ability to attend appointments or blood tests. A simpler regimen may help when clinically appropriate. Include the person in decisions even when others assist with administration, using appropriate consent and support.
Track outcomes that matter, such as participation, sleep, mood, mobility, and independence. New falls, confusion, severe sedation, or other acute symptoms need assessment. A good plan protects both mental health and daily functioning without treating adverse effects as inevitable aging.
Distinguish a new illness from a treatment-related change
New confusion, falls or marked sleepiness should prompt assessment rather than being attributed automatically to aging or dementia. An infection, dehydration, a recent hospital stay or a medication change may contribute. Ask when the problem began and whether any prescription, over-the-counter remedy or as-needed medicine was added. A timeline can help the team identify possibilities, but it does not prove a single cause. Sudden confusion or another acute change may need urgent care rather than a routine medication appointment.
The same principle applies to persistent low mood or anxiety. These symptoms deserve proper assessment and should not be dismissed as inevitable in later life. An established psychiatric diagnosis may remain relevant even when physical health becomes more complex. Treatment can support independence and quality of life, provided benefits and risks are reviewed. Family observations may be useful with the person's consent, while the person's own priorities should remain central. A medicine review should complement investigation of new symptoms instead of replacing it.
Look at the cumulative burden of the whole regimen
Several medicines can contribute to drowsiness, dizziness or other effects even when each prescription has a reasonable purpose. Include nonprescription sleep aids, allergy remedies and medicines taken only occasionally. Some products with anticholinergic effects can add to problems such as dry mouth, constipation or confusion. The hydroxyzine guide is an example of why an anxiety medicine's broader effects need consideration. The appropriate response depends on the full regimen and clinical history rather than on removing a medicine solely because of age.
Ask the pharmacist or prescriber to review overlapping effects as well as direct drug interactions. Falls risk, blood-pressure changes, kidney function and swallowing difficulties may alter the assessment. A treatment that caused little difficulty previously can become harder to tolerate after an illness or another prescription is added. Report new symptoms and ask which checks are needed. Simplifying the schedule or changing a product may help, but every alteration should have a stated purpose and a plan to protect treatment benefit.
Make deprescribing a shared clinical decision
Deprescribing means reviewing whether a medicine still offers enough benefit and, when appropriate, reducing or stopping it with support. It is not a target to reach the smallest possible number of prescriptions. A medicine may prevent a serious recurrence even when symptoms are currently absent. Another may have been started for a temporary problem that has resolved. Ask what evidence supports continuation, what risks reduction could introduce and how the team would recognize a problem if treatment changes.
For medicines associated with withdrawal, the plan should address that risk separately from recurrence of the original illness. Stopping several products together can make new symptoms difficult to interpret. The clinician may prioritize changes according to immediate risks, benefit and patient preference. Agree on follow-up and what to do if the person feels worse. The antidepressant overview can help explain a medicine's role, but a general guide should not be used as a taper schedule or a reason to stop a stable regimen independently.
Adapt medication support while preserving choice
A medicine may be appropriate yet difficult to use because of small print, packaging, memory problems or reduced dexterity. Ask for accessible instructions and a suitable way to organize supplies. A pharmacist can confirm whether a particular formulation can be split, crushed or supplied differently; these changes are not safe for every product. Check that the person can open packaging and understands which medicines are regular and which are as needed. Practical barriers should be addressed before assuming treatment is ineffective.
If a family member or caregiver helps, agree on their responsibilities and the person's preferences for information sharing. Keep an updated medicine list for appointments and hospital visits, with reasons for prescribing and any recent changes. After discharge, confirm which pre-existing products have stopped so that old and new prescriptions are not taken together accidentally. People living independently may need a different arrangement from those receiving daily support. Review the plan when health, vision, memory or the available help changes, while protecting autonomy wherever possible.
Making the next medication discussion useful
Bring one current list of medicines to the appointment, including the exact product, prescribed instructions, over-the-counter remedies, supplements and any medicines you take only occasionally. If the list in a clinic record is different from what you actually use, say so. Understanding the difference is more useful than trying to give an answer that sounds correct. A photograph of packaging can help clarify an unfamiliar brand or formulation.
Choose two or three priorities before the visit. These might be a persistent symptom, a side effect affecting daily life, a monitoring result or concern about continuing treatment. Describe when the problem began and whether it followed a change in medicine, illness, sleep or substance use. You do not have to diagnose the cause yourself. A clear timeline helps the clinician consider several explanations without automatically attributing everything to the psychiatric condition.
Leave with an agreed next step and a review date. If the plan changes, ask for written instructions that explain what each medicine is intended to do and whom to contact if a problem occurs. Check that the pharmacy and other prescribers have the updated plan. A useful review ends with responsibilities assigned, not simply with a recommendation to monitor the situation. Shared decisions should include your preferences, the available evidence and the practical ability to carry out the plan.
Related Medication and Treatment Guides
- What Is Hydroxyzine? Uses, Side Effects and Safety
- What are Antipsychotics
- What are Antidepressants
- Explore the Medication Guide
YOU MAY FIND THESE HELPFUL
A useful place to start.
Depression Treatment Center
ExploreUnderstandAnxiety Treatment Center
ExploreUnderstandInsomnia & Sleep Disorder Treatment Center
ExploreAssessment & Treatment Planning
ExplorePlan your stayHow Admission Works
ExploreUnderstandDepression Treatment Center
ExploreQuestions
Frequently Asked Questions
Does being older mean psychiatric medication should always be stopped?
No. Effective treatment can remain important for symptom control, independence and prevention of recurrence. Age-related changes, other illnesses and the whole medicine list should inform suitability and monitoring. A review may recommend continuation, adjustment or supported reduction. The decision should have a clear rationale rather than treating age or a prescription count as a reason to stop useful care.
What if confusion or falls start after a new prescription?
Seek clinical advice and provide the timing, exact medicine list and details of recent illness or hospital care. Medication may contribute, but other causes also need assessment. Sudden confusion, serious injury or another acute change warrants urgent care. Do not make several independent changes at once; a coordinated review is more likely to identify the problem and protect necessary treatment.
Should psychiatric medicine be avoided simply because someone is older?
No. Appropriate treatment can be valuable. The choice and monitoring should account for physical health, frailty, interactions, and the person's goals.
Can medication cause symptoms that look like aging?
Yes. Sedation, confusion, balance problems, and other effects can resemble or worsen age-related difficulties. New changes should be assessed rather than automatically accepted.
Are antipsychotics routine treatment for dementia-related distress?
They require particular caution and a clear indication. Contributors such as pain, delirium, and environmental problems should be assessed, and benefit and ongoing need reviewed.
Is deprescribing the same as stopping everything?
No. It is a supported review of whether particular medicines remain useful. Changes should account for withdrawal, recurrence, interactions, and follow-up.
Editorial evidence
Evidence & sources
Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.
View all 4 sourcesShow fewer sources
Clinical context
Clear information is framed around complex and co-occurring presentations.
Individual factors
Assessment remains essential because needs and risks differ from person to person.
Next steps
A confidential conversation can help clarify the most appropriate route forward.
Not sure where the situation fits?
Your admissions team
A confidential first conversation can help clarify the presentation and whether our setting is appropriate.